Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Amortization of Deferred Charges: 2010-2025

Historic Amortization of Deferred Charges for OptimizeRx (OPRX) over the last 4 years, with Q3 2025 value amounting to $174000.0.

  • OptimizeRx's Amortization of Deferred Charges fell 439.56% to $174000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year increase of 6785.71%. This contributed to the annual value of $835000.0 for FY2024, which is 29573.46% up from last year.
  • Per OptimizeRx's latest filing, its Amortization of Deferred Charges stood at $174000.0 for Q3 2025, which was down 439.56% from $437000.0 recorded in Q2 2025.
  • OptimizeRx's 5-year Amortization of Deferred Charges high stood at $437000.0 for Q2 2025, and its period low was $174000.0 during Q1 2025.